BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI
3849 results:

  • 1. Predictors of renal function deterioration at one year after off-clamp non-renorrhaphy partial nephrectomy.
    Nakamura M; Kameyama S; Tsuru I; Izumi T; Ono A; Teshima T; Inoue Y; Amakawa R; Inatsu H; Yoshimatsu T; Kusakabe M; Morikawa T; Shiga Y
    PLoS One; 2024; 19(5):e0303104. PubMed ID: 38739585
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of dmft and behavior rating scores between children with systemic disease and healthy children at the first dental visit.
    Erbas Unverdi G; Ozgur B; Gungor HC; Casamassimo PS
    BMC Oral Health; 2024 May; 24(1):548. PubMed ID: 38730438
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study.
    Zhao QX; Wu C; Tan S; Yang Y; Cui XW; Dietrich CF; Yang B; Xu CL; Gao YY; Xie MX; Wu CJ; Liu LP; Wang XH; Ling-Hu RZ; Wang N; Wang F; Wang XL; Liu GY; Yu XL; Yu J; Cheng ZG; Liang P
    World J Urol; 2024 May; 42(1):302. PubMed ID: 38720010
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Management of renal sinus angiomyolipoma: modified robotic nephron-sparing surgery in a single center.
    Zhang Y; Zhang Z; Li F; Guan W
    BMC Urol; 2024 May; 24(1):103. PubMed ID: 38715034
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Robot-assisted partial nephrectomy in patients aged 75 years or older - comparing the risk of complications with their younger counterparts.
    Petersson RD; Fode M; Niebuhr MH; Rashu BS; Thomsen FF
    Aging Clin Exp Res; 2024 May; 36(1):107. PubMed ID: 38714631
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Totally retroperitoneal approach for robot-assisted nephroureterectomy with bladder cuff without repositioning.
    Hattori Y; Yamamoto A; Nagoshi A; Fujiwara T; Kambe T; Igarashi A; Akagi N; Shibasaki N; Kawakita M; Yamasaki T
    Asian J Endosc Surg; 2024 Jul; 17(3):e13317. PubMed ID: 38692582
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Open versus minimally invasive nephroureterectomy in octogenarians: An analysis of surgical approach trends, outcomes, and survival analysis with propensity matching.
    Trecarten S; Bhandari M; Abdelaziz A; Noel O; Liss M; Dursun F; Svatek R; Mansour AM
    Urol Oncol; 2024 Jul; 42(7):220.e9-220.e19. PubMed ID: 38631967
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. All-cause, cardiovascular disease and cancer mortality in the population of a large Italian area contaminated by perfluoroalkyl and polyfluoroalkyl substances (1980-2018).
    Biggeri A; Stoppa G; Facciolo L; Fin G; Mancini S; Manno V; Minelli G; Zamagni F; Zamboni M; Catelan D; Bucchi L
    Environ Health; 2024 Apr; 23(1):42. PubMed ID: 38627679
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Label-Free SERS of Urine Components: A Powerful Tool for Discriminating Renal Cell Carcinoma through Multivariate Analysis and Machine Learning Techniques.
    Buhas BA; Toma V; Beauval JB; Andras I; Couți R; Muntean LA; Coman RT; Maghiar TA; Știufiuc RI; Lucaciu CM; Crisan N
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612705
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function.
    Karaboyun K; İriağaç Y; Çavdar E; Avci O; Şeber ES
    J Cancer Res Ther; 2024 Jan; 20(1):144-149. PubMed ID: 38554312
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
    Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
    Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
    Van Genechten T; De Laere M; Van den Bossche J; Stein B; De Rycke K; Deschepper C; Hazes K; Peeters R; Couttenye MM; Van De Walle K; Roelant E; Maes S; Vanden Bossche S; Dekeyzer S; Huizing M; Caluwaert K; Nijs G; Cools N; Verlooy J; Norga K; Verhulst S; Anguille S; Berneman Z; Lion E
    BMJ Open; 2024 Mar; 14(3):e077613. PubMed ID: 38503417
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor.
    Palermo M; D'Elia C; Trenti E; Comploj E; Mian C; Schwienbacher C; Heidegger I; Clauser S; Pycha A; Vjaters E
    Minerva Urol Nephrol; 2024 Apr; 76(2):195-202. PubMed ID: 38498297
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis.
    Huang RS; Chow R; Chopade P; Mihalache A; Hasan A; Boldt G; Glicksman R; Simone CB; Lock M; Raman S
    Radiother Oncol; 2024 May; 194():110216. PubMed ID: 38462092
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.
    Kollerits B; Gruber S; Steinbrenner I; Schwaiger JP; Weissensteiner H; Schönherr S; Forer L; Kotsis F; Schultheiss UT; Meiselbach H; Wanner C; Eckardt KU; Kronenberg F;
    BMC Cancer; 2024 Mar; 24(1):320. PubMed ID: 38454416
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study.
    Chen S; Gao F; Guo T; Jiang L; Zhang N; Wang X; Zheng J
    Int J Surg; 2024 May; 110(5):2970-2977. PubMed ID: 38445478
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
    Siva S; Bressel M; Sidhom M; Sridharan S; Vanneste BGL; Davey R; Montgomery R; Ruben J; Foroudi F; Higgs B; Lin C; Raman A; Hardcastle N; Hofman MS; De Abreu Lourenco R; Shaw M; Mancuso P; Moon D; Wong LM; Lawrentschuk N; Wood S; Brook NR; Kron T; Martin J; Pryor D;
    Lancet Oncol; 2024 Mar; 25(3):308-316. PubMed ID: 38423047
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Perioperative Complications of Single-Port and Multiport Robotic Radical Prostatectomy: A Single Institutional Comparison Analysis.
    Soputro NA; Chavali JS; Ramos-Carpinteyro R; Mikesell C; Pedraza AM; Kaouk JH
    J Endourol; 2024 May; 38(5):450-457. PubMed ID: 38420656
    [No Abstract]    [Full Text] [Related]  

  • 20. Ultrasound image segmentation of renal tumors based on UNet++ with fusion of multiscale residuals and dual attention.
    Qi H; Wang Z; Qi X; Shi Y; Xie T
    Phys Med Biol; 2024 Mar; 69(7):. PubMed ID: 38412532
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 193.